MYC and hepatocellular carcinoma: Interestingly, cancer‐related pathways, such as cell cycle (MYC targets V1) and MTORC1 signalling, were also upregulated in both HCC and CLD samples, suggesting that these pathways may already be transcriptionally dysregulated in the precancerous lesion.